Rituximab and low dose oral immune modulating treatment to maintain a sustained response in severe pemphigus patients.
J Dermatolog Treat. 2019 Jun;30(4):340-345. doi: 10.1080/09546634.2018.1510173. Epub 2018 Sep 7.
J Dermatolog Treat. 2019.
PMID: 30086663